ALLO Investing Cash Flow

Allogene Therapeutics Inc · Investing Cash Flow

ALLO logo

ALLO Investing Cash Flow

Latest reported-$131.60M
ALLO Cash from Investing ($0.00 → -$131.60M)
High-resolution chart · PNG

ALLO investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
95,559,000
75,688,000
163,289,000
106,159,000
163,655,000
-505,123,000
164,084,000
-632,798,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.